Matthew Smith

6.0k total citations · 2 hit papers
63 papers, 4.3k citations indexed

About

Matthew Smith is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matthew Smith has authored 63 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 27 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matthew Smith's work include Prostate Cancer Treatment and Research (26 papers), Bone health and treatments (23 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). Matthew Smith is often cited by papers focused on Prostate Cancer Treatment and Research (26 papers), Bone health and treatments (23 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). Matthew Smith collaborates with scholars based in United States, Canada and United Kingdom. Matthew Smith's co-authors include Allan Lipton, Robert E. Coleman, Fred Saad, Pierre Major, Richard J. Cook, Ker‐Ai Lee, Teuvo L.J. Tammela, Ming Zheng, Philip W. Kantoff and Mary Anne Fallon and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Matthew Smith

59 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

2009 786 citations Matthew Smith, Blair Egerdie et al. New England Journal of Medicine profile →
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

2014 551 citations Philip W. Kantoff, Bertrand Tombal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Smith United States	25	2.7k	2.2k	1.2k	922	708	63	4.3k
RE Coleman United Kingdom	44	2.4k 0.9×	1.9k 0.9×	2.1k 1.7×	319 0.3×	592 0.8×	172	6.1k
Francis J. McGovern United States	29	1.6k 0.6×	4.4k 2.0×	1.0k 0.8×	500 0.5×	2.6k 3.7×	90	6.5k
Alexander Paterson Canada	34	4.0k 1.5×	1.1k 0.5×	1.5k 1.2×	906 1.0×	691 1.0×	104	5.1k
Alfredo Berruti Italy	37	2.0k 0.7×	1.3k 0.6×	470 0.4×	251 0.3×	517 0.7×	153	4.9k
Katia Tonkin Canada	33	4.4k 1.6×	887 0.4×	746 0.6×	623 0.7×	1.8k 2.6×	86	6.5k
Einat Even‐Sapir Israel	46	1.6k 0.6×	2.2k 1.0×	3.0k 2.5×	175 0.2×	236 0.3×	141	6.4k
Klaus Brasso Denmark	33	1.1k 0.4×	1.8k 0.8×	290 0.2×	203 0.2×	423 0.6×	200	3.5k
Claudio Ricci Italy	31	1.9k 0.7×	1.0k 0.5×	402 0.3×	232 0.3×	190 0.3×	179	3.8k
Umamaheswar Duvvuri United States	45	2.0k 0.7×	1.1k 0.5×	629 0.5×	111 0.1×	1.4k 1.9×	180	6.6k
Martin Gotthardt Netherlands	43	1.7k 0.6×	1.1k 0.5×	2.3k 1.9×	57 0.1×	826 1.2×	209	5.5k

Countries citing papers authored by Matthew Smith

Since Specialization

Citations

This map shows the geographic impact of Matthew Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Smith more than expected).

Fields of papers citing papers by Matthew Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Smith. The network helps show where Matthew Smith may publish in the future.

Co-authorship network of co-authors of Matthew Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Smith. A scholar is included among the top collaborators of Matthew Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Smith. Matthew Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fabricant, Daniel G., Sagi Ben-Ami, Igor Chilingarian, et al.. (2025). An Integral Field Unit for the Binospec Spectrograph. Publications of the Astronomical Society of the Pacific. 137(1). 15002–15002.

Warren, Andrew, Kirsten Dansey, Christopher R. Burke, et al.. (2024). Early outcomes of endovascular repairs of the aortic arch using thoracic branch endoprosthesis. Journal of Vascular Surgery. 80(1). 22–31. 4 indexed citations

Turco, Fabio, Silke Gillessen, Giorgio Treglia, et al.. (2023). Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 27(3). 385–392. 4 indexed citations

Smith, Matthew. (2023). The First Resort. Columbia University Press eBooks. 6 indexed citations

Smith, Matthew, et al.. (2022). Design and fabrication of a low-cost and programmable dip coating machine. HardwareX. 12. e00364–e00364. 4 indexed citations

Fizazi, Karim, Neal D. Shore, Teuvo L.J. Tammela, et al.. (2020). 223P Overall survival (OS) results of phase III ARAMIS study of darolutamide (DARO) added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC). Annals of Oncology. 31. S1328–S1328. 2 indexed citations

Smith, Matthew, et al.. (2019). Evaluation of Asymptomatic Microscopic Hematuria by Renal Ultrasound to Detect Upper Tract Malignancy: A 20-Year Experience in a Community Hospital. Urology. 133. 34–39. 7 indexed citations

Lipton, Allan, Matthew Smith, Karim Fizazi, et al.. (2016). Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents. Clinical Cancer Research. 22(23). 5713–5721. 32 indexed citations

Smith, Matthew, et al.. (2011). Excite and receive solenoid radiofrequency coil for MRI‐guided breast interventions. Magnetic Resonance in Medicine. 65(6). 1799–1804. 4 indexed citations

10.

Coleman, Robert E., Luís Costa, Fred Saad, et al.. (2011). Consensus on the utility of bone markers in the malignant bone disease setting. Critical Reviews in Oncology/Hematology. 80(3). 411–432. 65 indexed citations

11.

Hatoum, Hind T., Swu‐Jane Lin, Matthew Smith, Amy Guo, & Allan Lipton. (2011). Treatment Persistence With Monthly Zoledronic Acid is Associated With Lower Risk and Frequency of Skeletal Complications in Patients With Breast Cancer and Bone Metastasis. Clinical Breast Cancer. 11(3). 177–183. 17 indexed citations

12.

Coleman, Robert E., Allan Lipton, G. David Roodman, et al.. (2010). Metastasis and bone loss: Advancing treatment and prevention. Cancer Treatment Reviews. 36(8). 615–620. 97 indexed citations

13.

Michaelson, M. Dror, Meredith M. Regan, William Oh, et al.. (2009). Phase II study of sunitinib in men with advanced prostate cancer. Annals of Oncology. 20(5). 913–920. 123 indexed citations

14.

Smith, Matthew, Blair Egerdie, Narciso Hernández Toriz, et al.. (2009). Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer. New England Journal of Medicine. 361(8). 745–755. 786 indexed citations breakdown →

15.

Gralow, Julie R., J. Sybil Biermann, Azeez Farooki, et al.. (2009). NCCN Task Force Report: Bone Health in Cancer Care. Journal of the National Comprehensive Cancer Network. 7(Suppl_3). S–1. 152 indexed citations

16.

Smith, Matthew, Hang Lee, Mary Anne Fallon, & David M. Nathan. (2008). Adipocytokines, Obesity, and Insulin Resistance During Combined Androgen Blockade for Prostate Cancer. Urology. 71(2). 318–322. 93 indexed citations

17.

Smith, Matthew. (2007). Androgen deprivation therapy for prostate cancer: new concepts and concerns. Current Opinion in Endocrinology Diabetes and Obesity. 14(3). 247–254. 122 indexed citations

18.

Brown, J. E., Richard J. Cook, Pierre Major, et al.. (2005). Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors. JNCI Journal of the National Cancer Institute. 97(1). 59–69. 432 indexed citations

19.

Lipton, Allan, Eric J. Small, Fred Saad, et al.. (2002). The New Bisphosphonate, Zometa^®(Zoledronic Acid), Decreases Skeletal Complications in Both Osteolytic and Osteoblastic Lesions: A Comparison to Pamidronate. Cancer Investigation. 20(sup2). 45–54. 134 indexed citations

20.

Smith, Matthew, et al.. (2000). Using an MRI distortion transfer function to characterize the ghosts in motion-corrupted images. IEEE Transactions on Medical Imaging. 19(6). 577–584. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact